COVID-19

It All Comes Down to Energy

14622 views

The Threat Around Us

Animals, including Homo Sapiens, survive in an essentially toxic environment, surrounded by microorganisms, potential poisons, the risk of trauma, and adverse weather conditions. Evolutionary development has equipped us with complex machinery that provides defensive mechanisms when any one of these factors has to be faced. Before the discovery of microorganisms, medical treatment had no rhyme or reason, but killing the microorganisms became the methodology. The research concentrated on ways and means of “killing the enemy”, the bacteria, the virus, the cancer cell. The discovery of penicillin reinforced this approach. We are now facing a period of potential impotence because of bacterial resistance, failure of attempts to kill viruses, and the resistance to chemotherapeutic agents in cancer. Louis Pasteur is purported to have said on his deathbed, “I was wrong, it is the terrain that matters”, meaning body defenses.

Hans Selye, whose research into how animals defend themselves when attacked by any form of stress, led to his description of the General Adaptation Syndrome (GAS). He recognized the necessity of energy in initiating the GAS and its failure in an animal that succumbed to stress. He labeled human disease as “the diseases of adaptation”. In Selye’s time, there was little information about energy metabolism but today, its details are fairly well-known. The suggestion of a new approach depends on the fact that our defenses are metabolic in character and require an increase in energy production over and above that required for homeostasis. If the GAS applies to human physiology and that we are facing the “diseases of adaptation”, it is hypothesized that research should be applied to methods by which energy metabolism can be stimulated and mobilized to meet the stress.

Energy Deficiency, Defective Immunity, and COVID-19

There is evidence that energy deficiency applies to each of the diseases described here. It may be the unrecognized cause of defective immunity in Covid-19 disease. Although in coronavirus disease the clinical manifestations are mainly respiratory, major cardiac complications are being reported involving hypoxia, hypotension, enhanced inflammatory status, and arrhythmic events that are not uncommon. Past pandemics have demonstrated that diverse types of neuropsychiatric symptoms, such as encephalopathy, mood changes, psychosis, neuromuscular dysfunction, or demyelinating processes may accompany acute viral infections or may follow infection by weeks, months, or longer in viral recovered patients. Electrocardiographic changes have been reported in Covid-19 patients. The authors suggest that it may be attributed to hypoxia as one possibility. Because the total body stores of thiamine are low, acute metabolic stress can initiate deficiency. Thiamine deficiency has a clinical expression similar to that observed in hypoxic stress and the authors referred to it as pseudo-hypoxia. It is therefore not surprising that defective energy metabolism can express itself clinically in many different ways.

The present medical model regards each disease as having a separate cause, but the large variety of symptoms induced by thiamine deficiency suggest the ubiquitous nature of energy deficiency as a cause in common. Obesity, a reflection of high calorie malnutrition, has been published as a risk factor for patients admitted to intensive care with Covid-19. Thiamine deficiency was reported in 15.5-29% of obese patients seeking bariatric surgery. Hannah Ferenchick M.D. an emergency room physician commented online that many of her patients with Covid-19 had what she called “silent hypoxemia”. These patients had an arterial oxygen saturation of only 85% but “looked comfortable” and their chest x-rays “looked more like edema”  It has long been known that patients with beriberi had low arterial oxygen and a high venous oxygen saturation. All that would be needed to support the hypothesis of thiamine deficiency in some Covid victims would be finding a high venous oxygen saturation at the same time as a low arterial saturation. Also, edema is a very important sign of beriberi, and thiamine deficiency has been noted in critical illness.

Disrupted Autonomic Function

There have been many articles in medical journals describing dysautonomia, mysteriously in association with a named disease, but with no suggestion that the dysautonomia is part of that disease. More recently, there is increasing evidence that dysautonomia is a feature of chronic fatigue syndrome (CFS), manifested primarily as disordered regulation of cardiovascular responses to stress. Manipulating the autonomic nervous system (ANS) may be effective in the treatment of CFS. Dysautonomia is also a characteristic of thiamine deficiency. Patients with Parkinson’s disease begin to lose weight several years before diagnosis and a study was undertaken to investigate this association with the ANS. Costantini and associates have shown that high dose thiamine treatment improves the symptoms of Parkinson’s disease, although the plasma thiamine concentration was normal. They have also shown that high dose thiamine treatment decreases fatigue in inflammatory bowel disease, Hashimoto’s disease, after stroke, and multiple sclerosis. As already noted, it is also an important consideration in critically ill patients.

Multiple System Atrophy is a devastating and fatal neurodegenerative disorder. The clinical presentation is highly variable and autonomic failure is one of its most common problems. Dysautonomia was found to be a clinical entity in Ehlers-Danlos syndrome, a musculoskeletal disease, and this syndrome frequently coexists with Postural Orthostatic Tachycardia Syndrome (POTS), a disease that is included in the group of diseases under the heading of dysautonomia. Some cases of POTS have been reported to be thiamine deficient. This common condition often involves chronic unexplained symptoms such as inappropriate fast heart rate, chronic fatigue, dizziness, or unexplained “spells” in otherwise healthy young individuals. Many of these patients have gastrointestinal or bladder disorders, chronic headaches, fibromyalgia, and sleep disturbances. Anxiety and depression are relatively common. Not surprisingly the many symptoms are often unrecognized for what they represent and the patient may have a diagnosis of psychosomatic disease.

Immune-Mediated Inflammatory Diseases (IMIDs) is a descriptive term coined for a group of conditions that share common inflammatory pathways and for which there is no definite etiology. These diseases affect the elderly most severely with many of the patients having two or more IMIDs. They include type I diabetes, obesity, hypertension, chronic pulmonary disease, coronary heart disease, inflammatory bowel disease, rheumatoid arthritis, Sjogren’s syndrome, systemic lupus, psoriasis, psoriatic arthritis, and multiple sclerosis. The recent recognition of small fiber neuropathy in a large subgroup of fibromyalgia patients reinforces the dysautonomia-neuropathic hypothesis and validates fibromyalgia pain. These new findings support the disease as a primary neurological entity.

Energy Deficiency During Pregnancy: The Cause of Many Complications

Irwin emphasized the energy requirements of pregnancy in which the maternal diet and genetics have to be capable of producing energy for both mother and fetus. He found that preventive megadose thiamine, started in the third trimester, completely prevented all the common complications of pregnancy. Hyperemesis gravidarum is the most common cause of hospitalization during the first half of pregnancy and is second only to preterm labor for hospitalization in pregnancy overall. This disease has been associated with Wernicke’s encephalopathy, well known to be due to brain thiamine deficiency. The traditional explanation is that vomiting is the cause, but since vomiting is a symptom of thiamine deficiency, it could just as easily be the cause rather than the effect. In spite of the fact that migraines are one of the major problems seen by primary care physicians, many patients do not obtain appropriate diagnoses or treatment. Migraine occurs in about 18% of women and is often aggravated by hormonal shifts. A complex neurological disorder involving multiple brain areas that regulate autonomic, affective, cognitive, and sensory functions, it occurs also in pregnancy. Features of the migraine attack that are indicative of altered autonomic function include nausea, vomiting, diarrhea, polyuria, eyelid edema, conjunctival injection, lacrimation, nasal congestion, and ptosis.

The Proteopathies: Disorders Involving Critical Enzymes

The earliest and perhaps best example of an interaction between nutrition and dementia is related to thiamine. Multiple similarities exist between classical thiamine deficiency and Alzheimer’s disease (AD), in that both are associated with cognitive deficits and reductions in brain glucose metabolism. Thiamine-dependent enzymes are critical components of glucose metabolism that are reduced in the brains of AD patients. Senile plaques and neurofibrillary tangles are the principal histopathological marks of AD and other proteopathies. The essential constituents of these lesions are structurally abnormal variants of normally generated proteins (enzymes). The crucial event in the development of transmissible spongiform encephalopathies is the conformational change of a host-encoded membrane protein into a disease associated, fibril forming isoform. A huge number of proteins that occur in the body have to be folded into a specific shape in order to become functional. When this folding process is inhibited, the respective protein is referred to as being mis-folded, nonfunctional, and causatively related to a disease process. These diseases are termed proteopathies and there are at least 50 different conditions in which the mechanism is importantly related to a mis-folded protein. Energy is required for this folding process. Because of their reported relationship with thiamine, it has been hypothesized that mis-folding might be related to its deficiency on an energy deficiency basis.

It All Comes Down to Energy

A hypothesis has been presented that the overlap of symptoms in different disease conditions represents cellular energy failure, particularly in the brain. If this should prove to be true, the present medical model would become outdated. An attack by bacteria, viruses or an oncogene might be referred to as “the enemy”. The defensive action, organized and controlled by the brain, may be thought of as “a declaration of war” and the illness that follows the evidence that “a war is being fought”. This concept is completely compatible with the research reported by Selye. It underlines his concept that human diseases are “the diseases of adaptation”, dependent on energy for a successful outcome in a “war” between an attacking agent and the complex defensive actions of the body. Killing the enemy is a valid approach to treatment if it can be done safely. Unfortunately, the side effects of most medications sometimes makes things worse and that is offensive to the Hippocratic Oath. We badly need to create an approach to research that explores ways and means of supporting and stimulating the normal mechanisms of defense.

We Need Your Help

More people than ever are reading Hormones Matter, a testament to the need for independent voices in health and medicine. We are not funded and accept limited advertising. Unlike many health sites, we don’t force you to purchase a subscription. We believe health information should be open to all. If you read Hormones Matter, like it, please help support it. Contribute now.

Yes, I would like to support Hormones Matter. 

This article was published originally on May 11, 2020.

New Developments in High-Dose Thiamine: The Legacy of Antonio Costantini

21490 views

In partnership with his colleagues, the Italian doctor Antonio Costantini pioneered the use of high-dose thiamine for treating a range of neurological and inflammatory conditions, including Parkinson’s disease (and here), multiple sclerosis, fibromyalgia, inflammatory bowel disease, and chronic cluster headaches.

Sadly, in 2020, Dr. Costantini contracted COVID-19 and died. While his work is finished, his legacy of exploring the therapeutic benefits of high-dose thiamine endures. In the past year, several important studies on high-dose thiamine have been released. This review briefly describes two of these studies and several related resources.

High-Dose Thiamine for IBD Fatigue

In the January 2021 issue of Alimentary Pharmacology & Therapeutics, Palle Bager and colleagues published a randomized controlled trial examining whether oral high-dose thiamine helped relieve fatigue in patients with quiescent inflammatory bowel disease (IBD) and severe chronic fatigue. Following a regimen adapted from Costantini’s earlier pilot study and other Costantini studies, the patients in Bager’s trial received 600 to 1,800 mg of oral thiamine hydrochloride daily, based on weight and gender. The 40 patients in the study were randomized to either receive high-dose thiamine or a placebo for four weeks. Following a four-week washout period, the control and treatment groups switched for another four weeks of treatment/placebo, so that everyone in the study received both high-dose thiamine and a placebo. The trial found that high-dose thiamine produced large reductions in self-reported fatigue on the validated IBD fatigue scale that were both clinically and statistically significant. No statistically significant relationship was observed between the impact of high-dose thiamine and patients’ baseline thiamine deficiency status.

This study is significant for its use of a very rigorous evaluation method: a double-blind cross-over randomized controlled trial. Using this gold standard evaluation method, Bager and colleagues largely confirmed the findings of Costantini’s earlier pilot study. While the Bager study focused only on people with IBD, it provides reason to be optimistic that high-dose thiamine may be helpful for the other populations studied by Costantini and possibly for people with other neurological and inflammatory conditions.

Bager and colleagues suggest that the impact of thiamine in reducing fatigue among patients with IBD and chronic fatigue may be related to problems the patients experience with the active transport mechanism for thiamine:

While the effect of high-dose oral thiamine was highly significant in our study, its exact mechanisms still need to be explored and investigated. The theory of a dysfunction in thiamine transport from blood to mitochondria remains a plausible explanation. The participants in our study were exposed to high doses of thiamine which induces passive diffusion that will add thiamine to the cells and the mitochondria. Consequently, the carbohydrate metabolism can normalise, and a reduction of fatigue is likely to follow.

In a Letter to the Editor of Alimentary Pharmacology & Therapeutics, I urged consideration of an alternative hypothesis, grounded in thiamine’s property as a carbonic anhydrase inhibitor:

The inhibition of carbonic anhydrase isoenzymes by high-dose thiamine and the resulting production of carbon dioxide could lead to reductions in fatigue and other symptomatic improvement through one or more of four potential pathways: (a) by reducing intracranial hypertension and/or ventral brainstem compression; (b) by increasing blood flow to the brain; (c) by facilitating aerobic cellular respiration and lactate clearance through the Bohr effect; or (d) by dampening the pro-inflammatory Th-17 pathway, again through the Bohr effect, potentially mediated by reductions in hypoxia-inducible factor 1.

More background on my hypotheses on the potential mechanisms for the impact of high-dose thiamine, with full citations, may be found here. The authors’ thoughtful reply to my letter may be found here.

High-Dose Thiamine for COVID-19

Another important recent study on high-dose thiamine has been released on a preprint server and is currently under consideration at the journal Critical Care. The study found that administration of high-dose thiamine to 83 patients in Saudi Arabia who were critically ill with COVID-19 was associated with a 55% reduction in 30-day ICU mortality and a 51% reduction in in-hospital mortality, as well as a reduction of 81% in the incidence of thrombosis during their ICU stay. The patients received a median of 100 mg of thiamine (presumably intravenously) for a median of 7 days.

Unlike the Bager study, the COVID-19 study by Al Sulaiman and colleagues was a retrospective study using a case matching approach, rather than a prospective study using random assignment. The authors matched the patients treated with high-dose thiamine to other critically ill COVID-19 patients using propensity scores based on baseline characteristics and controlling for the use of systemic corticosteroids. Based on correspondence with the authors, I understand that the patients’ baseline thiamine levels were not measured and thus unavailable as a matching variable.

This study is significant for providing evidence of the potential of high-dose thiamine to help treat critically ill patients with COVID-19. As I noted in an earlier Hormones Matter blog post, a prior study had found that high-dose thiamine damped down the pro-inflammatory th-17 pathway associated with the COVID-19 cytokine storm, but that study did not involve the treatment of actual COVID-19 patients.  Outcome data from the Front Line COVID-19 Critical Care Alliance suggests that the combined use of Methylprednisolone, Ascorbic Acid (Vitamin C), Thiamine and Heparin  (the so-called MATH+ protocol) may be helpful for COVID-19, but those data do not isolate the impact of high-dose thiamine and do not compare outcomes for treated households to those of a comparison group.

A randomized controlled trial is needed to verify the results found by Al Sulaiman and colleagues and assess whether high-dose thiamine can reduce mortality from COVID-19 among critically ill patients. It would also be valuable to rigorously evaluate whether oral high-dose thiamine could help early stage COVID-19 outpatients avoid hospitalization by reducing the incidence of the COVID-19 cytokine storm. This could help reduce the burdens of hospitals in India, Brazil, and other countries with high COVID-19 caseloads.

Future Directions

I am hopeful that additional rigorous research will be conducted to assess the potential of high-dose thiamine to treat a range of neurological and inflammatory conditions. It is hard to imagine a better tribute to Costantini’s work than a series of additional randomized controlled trials evaluating whether the observations he made in his pilot and case studies hold up when tested with larger samples using rigorous methods.

In addition to the conditions studied by Costantini, I would also encourage research into whether high-dose thiamine could be helpful for people with myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) and the neurological complications of Ehlers-Danlos Syndrome (EDS) (such as those experienced by my daughter). In this Medium post (more technical discussion) and Health Rising post (less technical discussion), I explain why I think these populations could benefit from high-dose thiamine.

More recently, I documented the retrospective self-reported outcomes for 55 individuals with ME/CFS, EDS or Fibromyalgia who reported taking 200 mg of more daily of high-dose thiamine. Nearly two-thirds of the participants in this retrospective survey reported large benefits, most commonly in reducing fatigue, post-exertional malaise, and brain fog.  Interestingly, benefits were reported across a range of doses, including doses below those used by Costantini and Bager. Several study participants described high-dose thiamine as a game-changer that brought them substantial relief. The study has many limitations. For example, it was a small non-representative sample and based on self-reports only, but it is consistent with the potential of high-dose thiamine to provide large therapeutic benefits. I am hopeful it will help make the case for conducting more rigorous research in the future.

To the extent that Long COVID is similar to ME/CFS, I would also encourage the study of high-dose thiamine for people with this debilitating condition.

We Need Your Help

More people than ever are reading Hormones Matter, a testament to the need for independent voices in health and medicine. We are not funded and accept limited advertising. Unlike many health sites, we don’t force you to purchase a subscription. We believe health information should be open to all. If you read Hormones Matter, like it, please help support it. Contribute now.

Yes, I would like to support Hormones Matter. 

Image by AJS1 from Pixabay.

This article was published originally on June 10, 2021.

Might TCM Help in the COVID-19 Pandemic?

4279 views

In the fight against Covid-19, we need all hands on-deck. Whilst vaccination, physical distancing and strong hygiene practices remain priority interventions, one strategy that has received less attention in Western countries is the use of herbal and, in particular, Traditional Chinese Medicine (TCM) as a preventative and potentially therapeutic agent.

Before we dive in, it is important to state upfront that this article in no way seeks to promote TCM as a replacement for vaccination and other critical Covid measures, but rather to understand its potential as a complement to mainstream therapies. Further the application of TCM should always be done under the supervision of a qualified practitioner.

Background on Traditional Chinese Medicine

Traditional Chinese Medicine has been in use for over 2000 years in over 320 epidemics faced by China. Chinese herbal medicine therapy is essentially a mixture of herbs prescribed by Chinese herbalists depending on the patient’s illness and based on core diagnostic patterns (inspection, listening, smelling, inquiry, and palpation). Whilst focus on pathogens is important, treating patients as an organic whole is the focus of TCM hence the central role of herbal compounds which help the immune system and other body systems to prevent and/or respond to pathogens.

The core clinical theories on viral flu-like illnesses were established by Chinese medical practitioners as far back as the Han Dynasty (206 BCE–220 CE) in a foundational text called “The Discussion of Cold-Induced Disorders” (Shang Han Lun) written by Zhang Zhong-Jing. Since then TCM practitioners have continued to learn and evolve their treatments, and today there are over 100 TCMs available for use in treating epidemics.

In modern day China, TCM is routinely used alone and in tandem with Western allopathic medicine to treat a wide range of different health conditions. Similar branches of medicine are used in South Korea, Japan and other parts of Asia.

Traditional Chinese Medicine and Covid-19

Since the beginning of the Covid-19 outbreak in Wuhan in late 2019, TCM was widely deployed across China to slow down the surge in infections. This was in part influenced by the Chinese experience with using TCM during the SARS epidemic. Studies found that when compared with Western Medical Treatment alone, TCM could help to reduce SARS fatality rates, improve oxygen saturation in critically ill patients, and alleviate symptoms such as dyspnea. Other studies by Luo et al. in 2020 and Lau et al in 2005 found that TCM was an effective preventative measure for SARS.

Soon after Covid-19 appeared in China, the National Administration of Traditional Chinese Medicine (NATCM) commissioned a team of experts to develop a traditional Chinese herbal medicine treatment program for the virus. On 24 January 2020, the first case of an early stage Covid patient who was cured by TCM was reported in Beijing.[1] The following day, another cured patient was reported.[2]

On 27 January 2020, an updated traditional Chinese herbal medicine treatment program was issued by China’s National Health Commission and NATCM which required health authorities to use traditional Chinese herbal medicine alongside Western medicine in the treatment of Covid-19.[3] TCM practitioners break Covid down into seven different stages (prevention, observation, initial, middle, severe, critical and recovery), with different herbal treatments prescribed for each.

In March 2020, another clinical case went public showing that a herbal formulation recommended by China’s National Health Commission was effective in attenuating acute respiratory distress syndrome in a mild Covid-19 patient.

Since then several further case-studies and reviews of TCM used during the Covid-19 pandemic have been published demonstrating TCM’s therapeutic effects.  One such review, published last November concluded:

The combination of western medicine and TCM in treatment [is] of great significance for the prevention and treatment of COVID-19.

Effects Are Strongest With Early Interventions

Researchers find that TCM is most effective in addressing symptoms when applied early in the progression of Covid-19. In a May 2020 study of 102 early-stage Covid-19 patients treated with TCM, researchers found that “clinical symptom disappearance time was shortened by 2 days, the recovery time of body temperature was shortened by 1.7 days, [and] the average length of stay in hospital was shortened by 2.2 days”. They concluded that the “early intervention [with] TCM is an important way to improve cure rate, shorten the course of disease, delay disease progression and reduce mortality rate.” and that “the reason why TCM works is not only to inhibit the virus, but [it] might block the infection, regulate the immune response, cut off the inflammatory storm, and promote the repair of the body.’”

Further, Li et al.’s, 2020 meta-analysis showed that herbal medicines are effective in halting the progression of Covid-19 from mild to critical, decreasing hospitalization rates, shortening the duration of hospital stays, as well as alleviating COVID-19 associated symptoms like fever, cough, fatigue, and inflammation.

What Might Be the Mechanisms at Work?

Based on recent in silico results, numerous natural compounds from TCM botanicals have been found highly potent in blocking the enzyme function and membrane receptors of coronavirus.

In a meta analysis of the most used botanicals in TCM for Covid-19 published in October 2020, Huang et al. found the nine most common herbal ingredients were: Glycyrrhizae Radix Et Rhizoma (Glycyrrhiza inflata Batalin), Forsythiae Fructus [Forsythia suspensa (Thunb.) Vahl], Lonicerae Japonicae Flos (Lonicera Japonica Thunb.), Scutellariae Radix (Scutellaria baicalensis Georgi), Platycodonis Radix [Platycodon grandiflorum (Jacq.) A. DC.], Menthae Haplocalycis Herba (Mentha canadensis L.), Gardeniae Fructus (Gardenia jasminoides J.Ellis), Gypsum Fibrosum, and Moschus (Moschus anhuiensis).

Huang et al’s integrated network analysis on these nine herbs identified eighteen botanical compounds with drug-like potential. Ten of those compounds are flavonoid derivatives. Flavonoids are known to protect cell membranes, and have antioxidant and anti-inflammatory properties.

Huang et al. concluded that the therapeutic effect of these eighteen compounds for Covid-19 was in influencing the COX-2 and MAPK mediated inflammatory pathways. The COX-2 enzyme is induced during inflammation and tissue repair. Data shows that COX-2 plays a role in driving the lung inflammation and injury caused by Covid-19. The p38 MAPK pathway plays a crucial role in the release of pro-inflammatory cytokines such as IL-6 and has been implicated in acute lung injury and myocardial dysfunction. It is thought that the overwhelming inflammatory response in Covid-19 is caused in part by upregulated p38 activity.

Since the compounds studied by Huang et al have been used in dietary supplements for a long time, their toxicity is negligible, which makes them safe to be employed as prophylactic agents, under the supervision of an experienced health practitioner.

In March 2020, Zhang et al screened databases of anti-viral botanical compounds and found 13 compounds that exist in TCM also had potential anti-Covid-19 activity. 125 Chinese herbs were found to contain 2 or more of these 13 compounds, leading the authors to conclude that “Chinese herbal treatments classically used for treating viral respiratory infection might contain direct anti-2019-nCoV [Covid-19] compounds.”

A July 2020 study by Yang et al. went further, examining the active components of two TCMs – Qing-Fei-Pai-Du (QFPD) and Ma-Xin-Shi-Gan (MXSG), both used by the Chinese Government to treat Covid. Their research identified 129 active compounds which fell into four categories:  flavonoids, glycosides, carboxylic acids, and saponins. Together these compounds were found to regulate multiple complement, coagulation cascades and thrombin systems to interfere with infection pathways. One major compound in MXSG, glycyrrhizic acid (found in licorice), played an anti-inflammatory role in blocking toll-like-receptors (immune receptors that play an important role in Covid-19) and in suppressing IL-6 production (a predictor of respiratory failure in severe Covid cases).

In June 2020, Li et al. published the results of an in-vitro study of the antiviral activity of Lian hua qing wen (LH), a TCM patent medicine comprising 13 herbs, which is a recommended TCM COVID treatment according to Chinese Government Guidelines. They found that the treatment of Vero E6 cells (African Green Monkey kidney cells which have been used for Coronavirus research in cell-culture based infection models since 2003) with LH resulted in an inhibition of SARS-CoV-2 replication and a corresponding reduction in several pro-inflammatory markers at the mRNA level.

A study of Liu Shen, a TCM used widely for treating infectious diseases, which was conducted by Ma et al. in August 2020, found that it exerted inhibitory effects against SARS-CoV-2 replication and virus-induced inflammation in vitro probably via suppressing the NF-κB pathway. This pathway drives the expression of numerous pro-inflammatory genes, including those encoding for cytokines and chemokines. It also plays a role in regulating the inflammasome, which are innate immune system receptors and sensors that activate inflammatory responses in the presence of pathogens.

In a February 2021 paper, Capodice and Chubak highlight several molecules from a wide variety of TCM herbs that have potent antiviral and immune modulating properties in treating Covid-19. Further research is needed to confirm whether these molecules behave similarly when combined together.

What Could All of This Mean?

Whilst further research is needed to dig into the exact mechanisms and full potential of TCM in treating and preventing Covid-19, the initial findings are promising.

Herbal and Chinese Medicine have long been used to treat respiratory illness and viral infections. They have minimal toxicity, can be administered orally and are widely accessible, making them strong candidates for long-term prophylactic use.

Given that those with weaker immune systems are at greater risk of Covid-19 infection, herbal medicines like TCM which can help to modulate the immune system and dampen down the uncontrolled inflammation that occurs in Covid-19, could, as Lei and Liu conclude, offer potential as a preventive or even therapeutic agent alongside other Covid treatments.

As the Covid virus continues to mutate and countries grapple with the tragedy of this Pandemic, all modes of treatment that have minimal risks and proven benefits should be given serious consideration. Herbal and Traditional Chinese Medicine may be one such contender.

Additional Notes

[1] Article reads: “A patient diagnosed with 2019-nCoV pneumonia was discharged from Beijing”

[2] Article reads: “One patient with 2019-nCoV pneumonia was discharged today in Beijing, with a total of two discharged”

[3] Pneumonitis Diagnosis and Treatment Program for New Coronavirus Infection (Trial Version 4). In. Edited by The General Office of the National Health and Health Commission of China, Office of the State Administration of Traditional Chinese Medicine. Beijing; 2020.

[4] For example: Ren et al, Traditional Chinese Medicine for Covid Treatment, Pharmacological Research, May 2020; Zhang et al, The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence, Pharmacological Research, July 2020; Zhao et al, Prevention and treatment of COVID-19 using Traditional Chinese Medicine: A review, Phytomedicine, August 2020; Wu et al, Traditional Chinese Medicine as a complementary therapy in combat with COVID-19—A review of evidence-based research and clinical practice, Journal of Advanced Nursing, November 2020; Zheng et al, Efficacy of Traditional Chinese Medicine on COVID-19: Two Case Reports, Feb 2021.

We Need Your Help

More people than ever are reading Hormones Matter, a testament to the need for independent voices in health and medicine. We are not funded and accept limited advertising. Unlike many health sites, we don’t force you to purchase a subscription. We believe health information should be open to all. If you read Hormones Matter, like it, please help support it. Contribute now.

Yes, I would like to support Hormones Matter. 

This article was published originally on June 3, 2021 

COVID-19 and Thiamine: An Interview with Dr. Derrick Lonsdale

9843 views

In the summer 2013, a geneticist we were seeing for my daughter ordered a test. Little did I know that test would contribute to a change in the course of my daughter’s life as well as a new area of study and advocacy for my career. This is my first time to write for Hormones Matter, so let me start by introducing myself. I am Kristi Wees and I am a pediatric patient advocate with EmpoweredAdvocacy.com as well as a national consultant for patient advocacy, empowerment, and engagement in the field of pediatric genetics. I was trained as a chemist at Penn State University with graduate training at UCLA. It was the journey that my daughter’s health took our family on that made me realize exactly why I had studied chemistry.

Fast forward to 2020, nearly 7 years later and now a pandemic with COVID-19, and I again realize how that 2013 test has sent us on an incredible journey. That 2013 test was for transketolase, which is a blood test to determine a vitamin (thiamine, B1) insufficiency. At the time, my daughter was struggling with autistic-like behaviors, severe fatigue, suspected mitochondrial disease, gastrointestinal concerns, severe food intolerances, and chemical sensitivities. The future looked bleak and hopeless.

After this test result came back, I began to search the literature about thiamine and found the work of Dr. Derrick Lonsdale. With guidance and a prescription from our medical team, we began our daughter on thiamine supplementation. In 2016,  I had the distinct honor of meeting Dr. Lonsdale in person. In 2019, I had the honor of interviewing him with Patricia Lemer for an episode called, “I Have A Child Who…Has Tantrums”.

Dr. Lonsdale
Our first meeting in 2016, from left to right: Kristi Wees (author of this post), Dr. Derrick Lonsdale, and Patricia Lemer (author of Outsmarting Autism).

A few weeks ago, I was reading the medical literature (here, here, and here) and watching anecdotal reports (here) regarding COVID-19 and began to see some clues that made me think of Dr. Lonsdale’s work on thiamine. I reached out to him via email and he shared with me that he too was seeing similar red flags and that he was frustrated because at 96 years old, and having dedicated his life to research on this vitamin, he believed it could be helping so many critically ill patients. He asked if I had any ideas about how to help him get the word out.

Here is the idea we came up with: a recorded interview. Dr. Lonsdale is a gentleman with whom I have come to know as a friend, mentor, and researcher and whose body of work helped my child thrive. I believe he possesses wisdom that has been forgotten and largely ignored by modern medicine. Listen to the interview, you won’t be disappointed.

Interview With Dr. Derrick Lonsdale: Thoughts on COVID-19

Dr. Derrick Lonsdale’s thoughts on COVID19 from Empowered Advocacy on Vimeo.

Shortly after releasing the video last week I came across this study: Intravenous Thiamine Is Associated With Increased Oxygen Consumption in Critically Ill Patients With Preserved Cardiac Index. Which again confirms Dr. Lonsdale’s conviction that thiamine can greatly improve the current situation in many ICU’s nationwide.

After treatment with thiamine, and many dietary, environmental and lifestyle changes, plus a whole lot of answered prayers, my daughter is thriving today with no residual behavioral, medical, neurological, developmental or learning challenges. Could thiamine also help overcome COVID-19? Possibly.

We Need Your Help

More people than ever are reading Hormones Matter, a testament to the need for independent voices in health and medicine. We are not funded and accept limited advertising. Unlike many health sites, we don’t force you to purchase a subscription. We believe health information should be open to all. If you read Hormones Matter, like it, please help support it. Contribute now.

Yes, I would like to support Hormones Matter. 

We’re On Our Own With COVID-19

3503 views

Over the last several weeks, like many of you, I have been gripped by news of the coronavirus (COVID-19) pandemic. I spend hours reading the medical research, reviewing the statistical models, and following the first hand accounts of doctors and patients. Normally, I am not one disposed to anxiety, panic, or overreaction, but I have to admit, this virus scares the crap out of me. It’s not just that this is a novel virus to which none of us has immunity or that there are no treatments, or that it disrupts an absolutely critical physiological system, the renin-angiotensin aldosterone system (RAAS), or that it is highly contagious, those variables alone make COVID-19 dangerous. That would be sufficient to induce panic in anyone under normal circumstance, but these are not normal circumstances. The virus seems to have timed its appearance perfectly so as to exert the most damage; when population ill-health is soaring and world economic, political, and health systems are crumbling. We are fundamentally ill-prepared to confront such a threat. And this is terrifying.

COVID Exposes Our Weaknesses

As a way to slow the infection rate and spare hospital demand, social isolation and quarantine policies have been implemented around the world. All but essential industries have shut down, including non-essential healthcare e.g, non-emergency or non-COVID related healthcare. Governmental response, in the US at least, and in some other countries, has been unorganized at best, and blinded by malice, incompetence and corruption at worst. Inasmuch as healthcare systems here in the US were already at capacity and frequently more aligned with economics than health, this crisis will overwhelm even the best of them.

With poor infectious disease capabilities, the risk to the health and life of frontline practitioners is high. This will be magnified by skewed economic interests of hospital financiers. We are likely also to lose a substantial number of primary care physicians to this crisis, not necessarily to the illness itself, but to the economic restructuring that is inevitable. Medical practices whose economic stability rely on complicated, services-based billing, will become financially infeasible when those services cannot be ministered and they will shutter. Given that here in US we already have fewer per capita physicians than many other countries, this becomes an increasingly risky prospect for a population that has learned to rely on these services.

We are seeing hints of this economic collapse already in the hospitals including those not yet hit by the COVID wave. In anticipation of lost revenue from elective procedures, hospitals are canceling contracts with their employees, including those who will risk their lives to care for COVID patients. In the hospitals where COVID is building or has already hit, where the financial output required to treat this virus is enormous, especially with supply profiteering encouraged the administration, and where once again, elective procedures have been canceled, insolvency is close (here, here, here). Of course, the hospitals and the healthcare industry are not blameless in this impending financial fiasco. For decades now, unethical and outright corrupt medical billing practices have padded revenue streams by upcharging and upselling every single aspect of healthcare. Does a single aspirin really need to cost $25? It does indeed, if one’s financial wherewithal rests on a convoluted reimbursement system that more closely aligns with grift than legitimate cost accounting.

This is, of course, on top of the very real risk of morbidity and mortality facing all healthcare personnel on the frontlines of this pandemic. Everyone from the cleaning staff to the physicians is at risk and yet,  the solution reached by many seems more skewed towards protecting the bottom line rather than employees (here, here, here). While the costs of this pandemic are staggering, they are made infinitely worse by the economics of our current model of for-profit medicine. This does not bode well for the future of American healthcare, and perhaps, if there is an upside to this crisis, that is it. When we reach the other side, perhaps we can create a healthier and more sustainable model of healthcare, but we must survive this crash first.

We Are On Our Own With COVID

To survive, we must recognize that we are very much on our own with this pandemic, not just for our response to COVID but for general health as well. That is, we will be mostly left to treat ourselves in isolation unless or until we either come through to the other side or require hospitalization. We cannot simply go to our primary physicians for assistance, not only because there are no known medically effective treatments available for COVID, though many have been proposed, but primarily because many physicians are no longer available. Some have switched to telehealth, but the overwhelming demand posed by this virus has severely constricted already inundated practices. Considering that it took anywhere from 6 – 66 days to see a family care physician prior to COVID, it should not be surprising that a pandemic of this scale would further limit physician availability.

There is also the risk we present to everyone who might care for us should we seek out medical attention early in the disease process. Everyone whom we would come contact with would be exposed, particularly in the US where protective gear is limited. Finally, if we require hospitalization, the outcome is not always positive, especially if we require mechanical ventilation. According to the current data from New York, COVID related hospitalization corresponds with an approximately 18% mortality rate. The mortality rate relative to all cases, is much lower of course. Drilling down a bit, if the disease process progresses to the need for mechanical ventilation, the mortality rate skyrockets. Those data are not available yet here, but one report from China found 97% of COVID patients requiring ventilation died. In general, mechanical ventilation outcomes are not good, with mortality rates ranging from 30-40%.

In addition to the increased patient mortality associated with mechanical ventilation, it is here where physicians and other healthcare personnel are most at risk to contract COVID. From other pandemics, we know that risk of contracting the viral contagion ranged from 2.8-6.6X higher in practitioners involved in intubation and subsequent care for these patients. Given the lack of protective gear in the US, along with the higher transmissibility rate of COVID compared to some other viral pandemics, the risk to all healthcare personnel is much higher. And yet, the employers of these institutions are cutting contracts, reducing pay, refusing hazard pay of their frontline personnel, and in many cases, have yet to provide sufficient protective gear, with some hospitals even preventing staff from wearing self-purchased protective gear. This is unconscionable, and yet, not completely unexpected given the perverted financial and ethical mores of the American healthcare industry.

Not since the early frontier days have we Americans required medical self-sufficiency, or any self-sufficiency. We like to portray ourselves as rugged individualists, bootstrappers and the like, but in reality, we are deeply dependent upon each other. Recognizing our fundamental interdependence with each other is not such a bad thing. Where it becomes problematic is when we place our faith and our health into the hands of those whose primary interest is financial. This is what COVID is teaching us. The question is, are we listening?

If We Are On Our Own, We Need A Plan

With the current state of politics in the US, it seems likely that many of us will have to face this crisis without external assistance. The question is how do we do this? Or more importantly, how are you going to prepare for your survival. It sounds like I am being overly dramatic, and I hope I am, but in the event things continue to go south, we all need a plan. So these are the questions I pose. First, how are you going to minimize infection rates – yours, your family’s and your community’s. Second, if you become infected, what is your survival plan? Simply hoping that you will have one mild cases may not work. If you get lucky, sure, but if not, how do you plan to survive this illness? Think about it. What will you need? Do you have supplies in storage for the quarantine? If you have a family, have you decided how to tackle possible co-infection? What is the plan? Third, if you should become severely ill and require hospitalization, what is the plan then? How will you get there? Knowing that if it progresses to that point that you will put into isolation at the hospital, and you may or may not recover, have you made the appropriate arrangements for yourself and/or your family? If you recover, what is the plan then? And finally, considering the impact of this pandemic on the structure of healthcare in general, what is the plan to manage existing conditions, now and going forward? Are there things you might do differently because you might not have access to physicians? These are questions we must all ask ourselves. And who knows, maybe if we do this right, we’ll come out of this crisis, healthier and happier than before. Please share your plans below.

We Need Your Help

More people than ever are reading Hormones Matter, a testament to the need for independent voices in health and medicine. We are not funded and accept limited advertising. Unlike many health sites, we don’t force you to purchase a subscription. We believe health information should be open to all. If you read Hormones Matter, like it, please help support it. Contribute now.

Yes, I would like to support Hormones Matter. 

 

 

Image by Mabel Amber from Pixabay

What Can Selye Tell Us About COVID-19? Survival Requires Energy

7822 views

Host Defenses

Most people are aware that Louis Pasteur played a major part in the discovery of microorganisms, particularly those that affect our health. He is purported to have said on his deathbed “I was wrong: it is the terrain that matters”. He meant, of course, the natural defenses with which the human body is equipped. In fact, he was stating something that is simple to understand. All members of the animal kingdom, including humans, live in a hostile environment, the major contributor to which are the microorganisms that result in disease. I like to think of them as “the enemy” that represents a war-like attack that tests our naturally endowed defensive mechanisms. The paradigm in medicine that exists at present is quite simple, “kill the enemy”. What Louis Pasteur was saying applied to the idea that the attack by the enemy is automatically met by a complex of defenses. Each attack by the microorganism can be viewed as much like a war. The question is, what we can do to make sure that the defenses are as vigorous as Mother Nature intended them to be. In order to answer that question, I turn to the work of Hans Selye.

Selye and Stress

As I have mentioned in previous posts on this website, Selye was a medical student in Hungary. One thing that professors of medicine do for students is to present them with patients suffering from the various diseases with which they have been diagnosed. Well, Selye was not listening to the professor. He was observing the facial expression of each of the patients as they were presented. He came to the conclusion that they all looked very much the same, that it was a response to the stress imposed by the illness from which they were suffering.

After graduation, he immigrated to Canada and set up an Institute in Montréal with a specific intention to study the effects of stress. Selye defined “stress” as anything that attacked the status quo of an animal. It included infection and trauma. In the modern world, stress is considered as purely a mental phenomenon. That is incorrect. Stress is anything that requires physiological energy to resolve. It can come in the form of mental or life stress, but the energetic demands remain the same as if it were the stress of an illness.

Selye set out to try to discover its mechanisms. His studies were performed on thousands of rats which he injured in various ways. He concluded that if the animal was fit, it would adapt to or resist whatever stress was imposed. If it failed to adapt, or if the stress was overwhelming (for humans, as in a car accident), the animal would die. He explained this under the heading of what he called the General Adaptation Syndrome (GAS). He found that the various laboratory studies on the blood and tissues of the injured animals exactly replicated the information obtained from laboratory studies done on humans suffering from illness. He called human diseases “the diseases of adaptation”.

One of his remarkable conclusions was that this adaptation through the GAS required huge amounts of energy, although at that time, little was known about how this energy was generated. However, one of his students knew that vitamin B1 (thiamine) was an important part of energy generation and he was able to show that deficiency of this vitamin resulted in a replication of the GAS, without traumatizing the animal. We can conclude that a severe lack of thiamine might be the cause of what we call “shock” and a complete lack would be lethal. Today we have detailed knowledge concerning the role played by thiamine in the generation of cellular energy and this particularly applies to the part of the brain that organizes and controls our adaptive ability through the autonomic and endocrine systems. We know that the immune system is controlled by the automatic brain and a deficiency of the required energy surge would encourage a successful attack by the “enemy”.

COVID-19 and Other Viral Pandemics

In the case of the current viral pandemic, the coronavirus – COVID-19, infection and trauma are considered as the “enemy” requiring an energy dependent defensive reaction organized and controlled by the brain. Does Selye’s work apply to COVID-19 or any other viral pandemic? The answer to that question, based on convincing evidence, is that it does indeed apply. A recent discovery is that a combination of hydrocortisone, ascorbic acid and thiamine (HAT therapy) given intravenously, is a successful treatment for sepsis, a condition that is almost uniformly lethal. This is clearly an assistance in supporting the defensive mechanisms by damping down the associated inflammation and regulating oxidative metabolism in the production of energy. Recently, thiamine has been found to be useful in the treatment of people with chronic disease, strongly suggesting that defective energy metabolism is an important part of the pathology. It has been reported that in-patients, being treated for psychiatric symptoms, are at risk for developing the serious symptoms of a brain disease known as Wernicke Encephalopathy, well known to be due to thiamine deficiency.  Finally, a report from the Department of Infectious Diseases, Wenzhous Central Hospital, Zhejiang Province, China describes the symptoms of the patients with COVID-19 treated in that hospital. One of the major findings was hypokalemia (low concentration of potassium in the blood). Nausea and vomiting were described in some of the patients. There are pumps in the cell membrane that pump potassium into the cell and sodium out of it. These pumps are energy dependent and are inherently vital to the function and life of all cells in the body. It is failure in this pump mechanism that is responsible for a low potassium and that is why hypokalemia occurs in the vitamin B1 deficiency disease beriberi, perhaps the best known condition primarily associated with energy failure. Nausea and vomiting, perhaps nonspecific as they are, also occur in beriberi.

It is proposed here that stimulating energy metabolism might improve the defensive action organized and conducted by the brain, obeying the dictum suggested by Louis Pasteur. It assumes of course that the genetics of the patient decide the intricacies of the defense program, but the relatively new science of epigenetics shows that energy, derived from nutrition, can improve genetic status. We believe that we have shown evidence that thiamine and magnesium supplementation are inherently necessary in a population in which nutrition is imperfect. In light of the success using thiamine and vitamin C in sepsis, one of the many negative outcomes of COVID-19, might a similar approach be employed in the treatment here. Moreover, if we consider the requisite ‘energy’ required to stave off any illness, might we also consider bolstering the nutrient stores e.g. host defense in at-risk populations, as a way to reduce the risk and severity of the illness? Doing so may help ensure the adequacy of energy in meeting the unseen enemy.

We Need Your Help

More people than ever are reading Hormones Matter, a testament to the need for independent voices in health and medicine. We are not funded and accept limited advertising. Unlike many health sites, we don’t force you to purchase a subscription. We believe health information should be open to all. If you read Hormones Matter, like it, please help support it. Contribute now.

Yes, I would like to support Hormones Matter. 

Image by PIRO from Pixabay